January 26, 2022 Comments Off on New patent expiration for Allergan drug ALPHAGAN P Posted in: Uncategorized
Annual Drug Patent Expirations for ALPHAGAN+P Alphagan P is a drug marketed by Allergan and is included in two NDAs. It is available from one supplier. There are eight patents…
The post New patent expiration for Allergan drug ALPHAGAN P appeared first …
January 26, 2022 Comments Off on New patent for Otsuka drug REXULTI Posted in: Patent Added Annual Drug Patent Expirations for REXULTI Rexulti is a drug marketed by Otsuka and is included in one NDA. It is available from one supplier. There are six patents protecting…
The post New patent for Otsuka drug REXULTI appeared first on DrugPatentWat…
